Here is data found by MailMentor on AlloVir

AlloVir is a leading company in the development of novel cell therapies, with a focus on restoring and fighting viral infections. Founded in 2013, AlloVir, formerly known as ViraCyte, specializes in the creation of allogeneic, off-the-shelf virus-specific T-cell therapies (VSTs). These therapies are designed to treat or prevent severe viral infections and diseases in patients with T-cell deficiencies. AlloVir's innovative approach aims to provide effective solutions for patients with limited or compromised immune systems.

Find contacts at this company

Our AI enabled web scraper helps you prospects at AlloVir and similar companies

Find out how